HomeANIK • NASDAQ
add
Anika Therapeutics Inc
Previous close
$26.08
Day range
$25.50 - $26.27
Year range
$16.54 - $28.67
Market cap
378.13M USD
Avg Volume
56.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 40.52M | 6.85% |
Operating expense | 34.69M | -1.99% |
Net income | -4.51M | 56.39% |
Net profit margin | -11.14 | 59.18% |
Earnings per share | 0.09 | 125.00% |
EBITDA | -7.53M | 16.37% |
Effective tax rate | -0.96% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 68.63M | -13.93% |
Total assets | 263.74M | -22.22% |
Total liabilities | 55.21M | -10.21% |
Total equity | 208.54M | — |
Shares outstanding | 14.83M | — |
Price to book | 1.85 | — |
Return on assets | -8.97% | — |
Return on capital | -10.03% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -4.51M | 56.39% |
Cash from operations | -126.00K | 96.52% |
Cash from investing | -1.81M | -30.17% |
Cash from financing | -2.27M | -40.92% |
Net change in cash | -4.24M | 35.69% |
Free cash flow | -4.64M | -429.60% |
About
Founded
1983
Headquarters
Website
Employees
357